Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Kjeld Poulsen
Jul 07, 2022 2:12PM ET
Bottom is below 467
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Chr Hansen Holding A/S (CHRc)
BATS Europe
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| CHRH | Copenhagen | DKK | Real-time | |
| CHRc | BATS Europe | DKK | Delayed | |
| CHYHY | OTC Markets | USD | Delayed | |
| 0MR6 | London | DKK | Real-time |
Add to/Remove from Watchlist
Add to Watchlist
513.60
+5.50
+1.08%
- Volume: 408
- Bid/Ask: 513.20 / 516.60
- Day's Range: 510.20 - 514.40
Chr Hansen
513.60
+5.50
+1.08%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
CHRc Financial Summary
A brief financial summary of Chr Hansen Holding A/S as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.
Chr. Hansen Holding A/S reported earnings results for the first quarter ended November 30, 2022. For the first quarter, the company reported sales was EUR 309.5 million compared to EUR 268.2 million a year ago. Net income was EUR 49.5 million compared to EUR 46.2 million a year ago. Basic earnings per share from continuing operations was EUR 0.38 compared to EUR 0.35 a year ago. Diluted earnings per share from continuing operations was EUR 0.38 compared to EUR 0.35 a year ago.
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter
CHRc Income Statement
Gross margin TTM 55.28%
Operating margin TTM 26.75%
Net Profit margin TTM 18.14%
Return on Investment TTM 9.76%
Total Revenue Net Income
| Period Ending: | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 |
|---|---|---|---|---|
| Total Revenue | 309.5 | 327.9 | 318.3 | 303.6 |
| Gross Profit | 166.9 | 183.9 | 175.4 | 170 |
| Operating Income | 76.5 | 90.7 | 85.2 | 84.1 |
| Net Income | 49.5 | 62.1 | 58.3 | 58.5 |
CHRc Balance Sheet
Quick Ratio MRQ 0.75
Current Ratio MRQ 1.66
LT Debt to Equity MRQ 57.51%
Total Debt to Equity MRQ 60.5%
Total Assets Total Liabilities
| Period Ending: | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 |
|---|---|---|---|---|
| Total Assets | 3288.1 | 3316.8 | 3205 | 3142.9 |
| Total Liabilities | 1548.5 | 1492.9 | 1469.8 | 1501 |
| Total Equity | 1739.6 | 1823.9 | 1735.2 | 1641.9 |
CHRc Cash Flow Statement
Cash Flow/Share TTM 2.05
Revenue/Share TTM 9.57
Operating Cash Flow 11.38%
Cash Net Change in Cash
| Period Ending: | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 |
|---|---|---|---|---|
| Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
| Cash From Operating Activities | 33.4 | 116.9 | 61.8 | 57.6 |
| Cash From Investing Activities | -21.5 | -70.5 | -34.5 | -27.6 |
| Cash From Financing Activities | -36.3 | -24.6 | -30.4 | -33.1 |
| Net Change in Cash | -28.3 | 26.6 | 4.2 | -3.8 |
* In Millions of (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Chr Hansen Holding A/S
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Nikolaj Jeritslev
Oct 25, 2021 12:22PM ET
hit the bottom?
0
0
Jens Skov
May 17, 2019 10:53AM ET
strong company ... inviting and expanding ... always strong sales in Q1.. target next months 730
1
0
Polle Puzzle
May 17, 2019 10:53AM ET
Say when
0
0
Jens Skov
Apr 17, 2019 11:58AM ET
target 700 next months
1
0
Jens Skov
Apr 04, 2019 9:56AM ET
Solid momentum continues: 9% organic growth in the first 6 months of 2018/19
3
0
Jens Skov
Apr 04, 2019 9:56AM ET
Solid organic revenue growth of 9% in the first half of 2018/19: Food Cultures & Enzymes 10%, Health & Nutrition 11% and Natural Colors 5%. EBIT before special items increased by 10% to EUR 150 million, corresponding to an EBIT margin before special items of 27.0% up 0.8%-point compared to last year. In Q2, organic growth was 8%, and EBIT before special items increased by 11%. The overall outlook for 2018/19 remains unchanged.
0
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review